Venus Concept Inc.

$0.31+2.64%(+$0.01)
TickerSpark Score
45/100
Weak
100
Valuation
40
Profitability
10
Growth
44
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VERO research report →

52-Week Range1% of range
Low $0.25
Current $0.31
High $12.93

Companywww.venusconcept.com

Venus Concept Inc. , a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.

CEO
Rajiv Kanishka Liyanaarchchie De Silva
IPO
2017
Employees
292
HQ
Toronto, ON, CA

Price Chart

-86.99% · this period
$8.93$4.62$0.30Apr 03Oct 03Apr 06

Valuation

Market Cap
$578.19K
P/E
-0.01
P/S
0.01
P/B
0.22
EV/EBITDA
-0.60
Div Yield
0.00%

Profitability

Gross Margin
64.36%
Op Margin
-59.00%
Net Margin
-92.76%
ROE
-2268.26%
ROIC
-93.14%

Growth & Income

Revenue
$64.83M · -15.09%
Net Income
$-46,996,000 · -26.16%
EPS
$-66.28 · -869.01%
Op Income
$-27,184,000
FCF YoY
13.76%

Performance & Tape

52W High
$12.93
52W Low
$0.25
50D MA
$0.59
200D MA
$1.82
Beta
-0.06
Avg Volume
6.41M

Get TickerSpark's AI analysis on VERO

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Mar 26, 26Madryn Asset Management, LPbuy37,187
Mar 26, 26Madryn Asset Management, LPbuy37,500,000
Mar 26, 26Madryn Asset Management, LPbuy335,000
Mar 26, 26Madryn Asset Management, LPbuy1,575,810
Mar 26, 26Madryn Asset Management, LPbuy1,500,000
Mar 26, 26Madryn Asset Management, LPbuy0
Mar 26, 26EW Healthcare Partners, L.P.sell1,575,810
Mar 26, 26EW Healthcare Partners, L.P.sell1,500,000
Mar 26, 26EW Healthcare Partners, L.P.sell0
Sep 30, 25Madryn Asset Management, LPbuy545,335

Our VERO Coverage

We haven't published any research on VERO yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate VERO Report →

Similar Companies